Someone posted this morning that the spiking infection rate in Israel is "good news for leronlimab". This is just not true.

Good news for leronlimab will be something that gets it to the people. Rates can spike all of the world and if leronlimab is still on the sidelines, it doesn't make a damn bit of difference.

Good results from Brazil will be good news for leronlimab in connection with spiking infection rates, nothing more. Then and ONLY then will leronlimab potentially be considered as a potential therapy. All else is just wishful thinking.

So...where are our Brazil updates?!?